Opinions do matter in Healthcare: Structured Expert Elicitation – A statistical approach to decision making

Healthcare decision-making is complex, often requiring choices about treatments, technologies, or policies based on limited evidence.  

“Structured Expert Elicitation (SEE) has emerged as a powerful approach for addressing these gaps by eliciting expert judgments.” 

SEE not only enhances decision quality but also promotes transparency and accountability. In this blog, we will explore the role of SEE in healthcare, its benefits and best practices, as well as drawing insights from recent research by the ISPOR Task Force on SEE and the development of a custom-made protocol for long-term survival outcomes. 

Let’s start with understanding the value of SEE in health decision-making. 

Decisions in healthcare rely on evidence, which is sometimes insufficient or uncertain. In such cases, SEE can provide credible estimates by quantifying expert knowledge where direct evidence is unavailable or limited. 

“For example, expert input might help estimate the likely outcomes of a new drug treatment for a rare disease, the long-term efficacy on a new therapy, or the effectiveness of a diagnostic tool not yet widely used. The elicited quantities could then be used to validate modelled results or incorporated in the analysis as an additional source of information.” 

SEE brings rigour to expert judgement by following a structured approach. Rather than relying on informal opinions, SEE uses a systematic method to capture and validate expert knowledge, making it more robust and transparent for use in decision-making.

Five Key SEE Protocols 

There are five SEE protocols available, each with unique strengths: 

  1. Sheffield Elicitation Framework (SHELF)1: The SHELF protocol starts with individual elicitation followed by group discussions to reach a consensus. It promotes interaction between expert and peer assessment.
  2. Cooke’s Classical Method 2: This protocol weights expert judgments based on statistical performance on calibration questions.
  3. Modified Delphi Method3: Known for its iterative rounds of individual responses and feedback, the Modified Delphi recommends mathematical aggregation after a fixed number of rounds.
  4. Investigate, Discuss, Estimate, Aggregate (IDEA) Protocol 4: IDEA combines elements of the Delphi and Cooke’s methods, facilitating structured feedback and discussion after individual estimates. The final individual estimates are combined via mathematical aggregation and weights can be incorporated.
  5. Medical Research Council (MRC) Reference Protocol 5: This protocol defines a reference case for Health Technology Assessment (HTA), which includes individual elicitation with mathematical aggregation using equal weights. If justified, it also allows the use of modified elements of the framework. 
    Do you know you can elicit long-term survival outcomes using SEE? 

    Estimating long-term survival when data is lacking is a significant hurdle in HTAs and a common source of uncertainty in decision-making. While expert input for long-term survival estimation has become standard, the methods used to gather these insights can sometimes lead to results viewed as “guesstimates,” which may lower confidence in the values provided. Hence, a custom-made protocol for long-term survival outcomes is needed to overcome these issues.  

    In line with the ISPOR SEE Task force’s recommendation for further research,6 a custom-made elicitation framework has been designed specifically to enhance long-term survival estimates. This framework offers an interactive, structured approach including a scenario testing as the basis for group discussion to improve the credibility, accuracy, consistency, and transparency of expert judgments of survival quantities, making it a valuable addition to HTA and economic modelling efforts. 

    To conclude, SEE stands as a vital tool for healthcare decision-making, helping to bridge the evidence gap in areas where data is limited. By following structured methods and drawing on the insights of experts, healthcare providers and policymakers can make better-informed choices. As SEE continues to evolve, it promises to support more robust, evidence-based healthcare that serves patients and society effectively. 

    Leading methodologist in SEE, Dr Kate Ren (Director Statistics, ConnectHEOR & Senior Research Fellow at the University of Sheffield) will be presenting multiple research projects at ISPOR Europe 2024.  If you’re interested in learning more about SEE and the development of a custom-made protocol for long-term survival estimation, we invite you to attend our presentations. 

    For an in-depth discussion – come to booth #1400. 

     

    References: 

    1. Oakley JE, O’Hagan A. SHELF: the Sheffield Elicitation Framework
      (version 4).
      https://shelf.sites.sheffield.ac.uk/

    2. Cooke, R. M. (1991). Experts in Uncertainty: Opinion and Subjective Probability in Science. Oxford University Press.

    3. European Food Safety Authority (2014). Guidance on expert knowledge elicitation in food and feed safety risk assessment. EFSA Journal 2014, 12(6):3734, 278 pp. DOI: https://doi.org/10.2903/j.efsa.2014.3734

    4. Hemming V, Walshe TV, Hanea AM, et al. Eliciting improved quantitative judgements using the IDEA protocol: A case study in natural resource management. PLoS ONE 2018; 13: e0198468. 20180622. DOI: 10.1371/journal.pone.0198468.

    5. Bojke L, Soares M, Claxton K, et al. Developing a reference protocol for structured expert elicitation in health-care decision-making: a mixed-methods study. Health Technology Assessment (Winchester, England) 2021; 25: 1.

    6. Soares M, Colson A, et al. Recommendations on the Use of Structured Expert Elicitation Protocols for Healthcare Decision Making: A Good Practices Report of an ISPOR Task Force. Value in Health, Volume 27, Issue 11, 2024, Pages 1469-1478. 

              Leave a Reply

              Your email address will not be published. Required fields are marked *

              Judit Banhazi

              Specialty
              Value and Access

              Role
              Vice President

              Degree
              MD Medicine, JD Law

              Judit Banhazi

              MD Medicine, JD Law

              Judit Banhazi, based in Basel, Switzerland, brings over 20 years of experience in HEOR, Market Access, and Health Policy.
              She has led HEOR strategies in hematology and initiated EU HTA policy activities. Judit began her career as a physician and has worked at prime global pharma companies. Her academic prowess is excellent with a peculiar combination of an MD in Medicine and a JD in Law, she has been at forefront of health economics by being involved in HTA policy discussions with EFPIA and HTAi.
              Known for her collaborative spirit and practical approach, Judit is passionate about learning and delivering quality work. Outside of work, she enjoys spending time with family and friends, travelling, and running.

              Adam Ball

              Specialty
              Business Development Manager

               

              Adam Ball

              Business Manager

              I am delighted to be part of the team here at ConnectHEOR. To tell you a bit about me, I have 10 years experience within Talent Acquisition within HEOR, RWE and Market Access. I have built a global network during this time and am excited to utilize this to help us grow as business. 

               

              Outside of work I love sports, playing football and squash regularly, as well as going to the gym. I also enjoy watching sports mainly football and tennis. I have a new born daughter too so she is taking up a lot of my time and is a bundle of joy. I also play drums and like to think I have a broad taste in Music.

               

              Eleni Tente

              Specialty
              Medical writing, Evidence planning

              Role
              Consultant, Medical writer

              Degree
              PhD – Molecular biology and genetics

              Eleni Tente

              PhD – Molecular biology and genetics

              Eleni Tente is an experienced medical writer with proven ability to translate complex scientific information into clear, concise, and impactful content to diverse audiences. She has a strong background in integrated evidence planning, publications, internal communications and e-learning development, complemented by an understanding of various therapeutic areas.

              Eleni holds a PhD in molecular biology and genetics from the University of Cambridge and an MSc in plant genetic manipulation from the University of Nottingham.

              In her free time, Eleni enjoys diving into a good book, fishing along the coast, or planning her next thrilling scuba diving adventure to swim with sharks.

              Syed Salleh

              Specialty
              HTA Modelling and Discrete-event Simulation

              Role
              Consultant, Modeling & Analytics

              Degree
              PhD – Health & Related Research

              Syed Salleh

              PhD. Health & Related Research

              Syed Salleh brings extensive experience in HTA modeling, having successfully led the development of both de novo and adaptation models for HTA listings across multiple countries, including Malaysia, Philippines, and the UK. His work spans key therapeutic franchises such as oncology, cardiometabolic, and respiratory. Syed has also delivered critical insights to healthcare professionals through MYSPOR, ITTP, and IKN virtual CME events and numerous publications.

              He holds a PhD in Health and Related Research from the School of Health and Related Research (ScHARR) at the University of Sheffield, UK, with a specialization in HTA and operational research, specifically in discrete-event simulation (DES) technique.

              During his time in a leading pharmaceutical company, Syed played a key role in securing the listing of several key products in the Malaysia Ministry of Health Formulary and served as the primary contact for DES-related projects.

              Besides work, Syed enjoys traveling, listening to music, and spending quality time with his family.

              Thai-Son Tong

              Specialty
              Model Conceptualization and Data Analytics

              Role
              Senior Consultant

              Degree
              PhD – Health Economics

              Thai-Son Tong

              PhD. Health Economics

              Thaison Tong has extensive work experience in health economics, decision modelling and big data analysis. He has a unique mix of experience in HEOR and RWE related research in academia and pharmaceutical industry. His expertise lies in health technology assessments (HTA), health economic modelling, simulation modelling, big data analytics and decision analysis. He has hands-on experience in a range of software and programming languages including R, R Shiny, R Markdown, Python, MS Excel, VBA, and Simul8. He has substantial experience of the health care system in the UK and other European countries.

              Thaison has direct experience in building cost-effectiveness models from scratch and conducting big data analysis in several disease areas including dementia, vascular disease, and cancer.

              Thaison’s PhD focus was to develop a de novo patient level model for the evaluation of different cognitive screening tests for early detection of dementia and mild cognitive impairment in primary care. He also looked at different methods for conducting economic evaluation in health care taking a broader/societal perspective. In addition, he investigated the use of Multiple Criteria Decision Analysis (MCDA) for economic evaluation.

              Thaison also holds Academic Researcher position in School of Health and Related Research (ScHARR), University of Sheffield, UK and Honorary Researcher position in University of Bristol, UK.

              Thaison’s likes to meditate, and play badminton, basketball and tennis.

              Shilpi Swami

              Specialty
              Consulting and strategy

              Role
              Vice President

              Degree
              MSc. International Economics

              Shilpi Swami

              MSc. International Economics

              Shilpi Swami is a seasoned Health Economics and Outcomes Research (HEOR) expert with experience spanning across multiple healthcare systems and therapy areas. At her current role of Vice President, HTA and Strategy, ConnectHEOR, she provides technical and strategic leadership. Additionally, Shilpi serves as the Member Engagement Co-Chair at ISPOR Oncology Special Interest Group.

              Shilpi has a comprehensive track record of leading HTA submissions and devising market access strategies on a global scale, including the EU-5, Canada, US, Latin America, Australia, and Asia. Shilpi has worked across various sectors within health economics, including academia, consulting, and biopharma. This multidimensional experience equips her with a unique ability to offer strategic insights from various stakeholders’ perspectives.

              Formerly a Research Fellow at the University of York, Shilpi has made significant contributions to public health projects and the development of best practices in the academic side of health economics. In her professional endeavors, she remains dedicated to improving healthcare through data-driven insights and evidence-based research

              Hugo Pedder

              Specialty Statistical Analysis and Evidence Synthesis

              Role Senior Consultant

              Degree PhD – Statistical Modelling

              Hugo Pedder

              PhD – Statistical Modelling

              Hugo brings in a wealth of experience to ConnectHEOR from his extensive work in academia, focusing primarily on evidence synthesis and meta-analysis. Hugo holds PhD in Statistical Modelling from University of Briston and MSc in Medical Statistics from the London School of Hygiene and Tropical Medicine, and his background in neuroscience remains a passionate interest. Alongside working with ConnectHEOR, Hugo continues to part of NICE committee. His expertise includes advanced indirect treatment comparisons technique and has extensive experience of working with the NICE in UK. 

              Beyond professional endeavors, Hugo is an enthusiastic outdoor adventurer, particularly enjoying mountain activities, climbing and ski mountaineering. From building rafts to exploring rivers in north of Sweden, he has lived an adventurous life outside of work and plans to continue to do so.

              Kunal Hriday

              Specialty
              Data science and Strategy

              Role
              Senior Consultant

              Degree
              MSc. Quantitative Economics

              Kunal Hriday

              MSc. Quantitative Economics

              Kunal Hriday is a business strategy and data science professional with experience in helping organizations crack through notorious business challenges. Kunal is proficient in business analytics, data analytics, product lifecycle management and business development. Working as a Data analytics consultant he has spent time in problem solving across variety of industries including Banking, logistics and Health and is now fully dedicated to HEOR. Kunal has hands on experience in various statistical programming tools and languages like R, Python, SAS, Excel VBA, Data Robot and data visualization tools like Power BI, Tableau and SAS VA.

              Kunal also holds a Masters in Quantitative Economics from Indian Statistical Institute and a bachelors degree in Business Economics. Excellent in business communication, he is passionate about studying environmental economics and related theories of welfare optimization.

              Raju Gautam

              Specialty
              Evidence Review

              Role
              Principal Consultant

              Degree
              PhD (Pharmacy)

              Raju Gautam

              PhD Pharmacy

              Raju Gautam spearheads evidence review at ConnectHEOR and  has extensive work experience in evidence review and synthesis, value communications, scientific publications, medical writing and project management.
              His expertise lies in systematic and targeted literature reviews, meta-analyses, network meta-analyses, value communications (AMCP and Global Value Dossiers), RWE study design and publications (manuscripts, posters, and abstracts).
              He has experience working in Global pharma companies, consulting and CRO environment for several therapy areas including Cardiovascular, Oncology, Neurology, Respiratory, Ophthalmic, Rare Diseases, and Vaccines. He has more than 40 publications in international journals as an author.
              Raju also likes jogging, yoga and meditation.

              Radha Sharma

              Specialty:
              Patient preference research, survey, In-depth interviews, COA, Evidence review and conceptualisation of study

              Role:
              Director – Patient-Centered Outcomes Research

              Degree:
              MBBS (Bachelor of Medicine and Bachelor of Surgery), PhD (Global Public Health) – University of York

              Radha Sharma

              PhD (Global Public Health)

              Radha Sharma spearheads Patient-Centered Outcomes Research at ConnectHEOR. She has a background in medicine, public health, and epidemiology.

              Her expertise includes global health research, preference elicitation, mixed-method studies, consensus workshops, qualitative health research, epidemiological analysis of big data sets, RWE study design, scientific writing, and literature reviews. Her primary focus is integrating patient perspectives into all stages of health technology assessment (HTA) and healthcare decision-making processes.

              Her extensive expertise in mixed-method studies and active patient/stakeholder engagement ensures that her research is methodologically rigorous and patient-centric. Radha is an avid hiker and enjoys exploring the beautiful Canadian Rockies.

              Kate Ren

              Specialty
              Statistical Analysis and Evidence Synthesis

              Role
              Director of Statistics

              Degree
              Ph.D Probability and Statistics

              Kate Ren

              PhD Probability and Statistics

              Kate spearheads Statistics and Evidence Synthesis at ConnectHEOR. She has more than 10 years of experience in conducting statistical analysis in HTA. Kate has PhD in Probability and Statistics specialising in Bayesian methods in clinical trial design.

              She specializes in Bayesian methods in health economics and the elicitation of experts’ beliefs and has extensive experience of conducting evidence synthesis, including, meta-analysis, network meta-analysis, MAIC, STC, ML-NMR etc. Besides working with ConnectHEOR, she is also a part of NICE Committee and University of Sheffield.

              Tushar Srivastava

              Specialty
              Decision Modelling and AI Initiatives

              Role
              Director and Principal Consultant

              Degree
              MSc – Statistics and Computing

              Tushar Srivastava

              MSc – Statistics and Computing

              Endorsed as a ‘Global Talent’ by prestigious ‘The Royal Society, UK’, Tushar is dynamic and enjoys approaching complex problems with a holistic approach. He also holds an MSc. in Statistics and has authored a handbook on higher Mathematics, “A concise handbook of vector space theory and field theory, Srivastava T.”

              In ConnectHEOR, Tushar spearhead all HEOR activities.

              Tushar’s technical expertise lies in different techniques including cost-effectiveness modelling, budget impact modelling, simulation modelling, statistical modelling and indirect comparisons analysis. He brings a unique blend of academic research, technical modelling and statistical skills and industry professionalism to support the life science industry at every stage of the product life cycle. He has a good experience in statistical analyses, including survival analysis and health related quality of life data analysis from clinical trials.

              Besides work, Tushar enjoys playing badminton, jogging, and meditating.